New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc.
Industry: Life Sciences ・ $ELVN on Nasdaq ・ Market Cap: Small
CEO Recent Sales
Top Executive Recent Sales
Regular Sale Insiders
High Sales Frequency
High Trades Frequency
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
| TRADES PURCHASE/SALE Sector Average | 0 / 101 2.19 / 7.65 |
| INSIDER BUYERS/SELLERS Sector Average | 0 / 10 1.2 / 2.5 |
| SHARES PURCHASED/SOLD Transaction Average | 0 / 4,182,209 0 / 41,408 |
| VALUE PURCHASED/SOLD Transaction Average | $0 / $83,243,015 $0 / $824,188 |
| PURCHASE RANGE | N/A |
| SALE RANGE | $533 - $22,877,262 |
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
0 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
3 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
No Insider Trades made
0%
DIRECTORS
0%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | N/A 0.2 |
VALUE GINI INDEX Sector Average | N/A 0.206 |
1Y SALE DISTRIBUTION
sale distribution by individual insiders
60.49%
DIRECTORS
7.7%
OFFICERS
31.81%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.548 0.295 |
VALUE GINI INDEX Sector Average | 0.573 0.288 |
Enliven Therapeutics, Inc. 1Y Trade Transactions
Submission Date Period of Report | Insider | Position | Total Value | Shares | Share Price | Ownership % Change | Shares Owned | Post Day Stock Change | Post Week Stock Change | |
|---|---|---|---|---|---|---|---|---|---|---|
2024-10-30 2024-10-28 | Hohl Benjamin | Officer | -$180,000 | 6,250 | $28.8 | -100% | 0 | -1.90% | +2.15% | |
2024-10-22 2024-10-18 | Patel Anish | Officer | -$21,480 | 716 | $30 | -0.21% | 343,311 | +0.41% | -2.04% | |
2024-10-22 2024-10-18 | Lyssikatos Joseph P | Officer | -$25,410 | 847 | $30 | -0.08% | 1,015,188 | +0.41% | -2.04% | |
2024-10-22 2024-10-18 | Kintz Samuel | Director | -$27,720 | 924 | $30 | -0.09% | 1,002,892 | +0.41% | -2.04% | |
2024-10-22 2024-10-18 | Hohl Benjamin | Officer | -$24,420 | 814 | $30 | -100% | 0 | +0.41% | -2.04% | |
2024-10-22 2024-10-18 | Heyman Richard A. | Director | -$24,510 | 817 | $30 | -0.43% | 188,245 | +0.41% | -2.04% | |
2024-10-22 2024-10-18 | Heyman Richard A. | Director | -$22,590 | 753 | $30 | -0.4% | 188,245 | +0.41% | -2.04% | |
2024-10-22 2024-10-18 | Collins Helen Louise | Officer | -$24,480 | 816 | $30 | -100% | 0 | +0.41% | -2.04% | |
2024-10-17 2024-10-15 | Heyman Richard A. | Director | -$35,141 | 1,270 | $27.67 | -0.66% | 189,815 | +3.43% | +3.85% | |
2024-10-10 2024-10-08 | Lyssikatos Joseph P | Officer | -$1,446,381 | 51,145 | $28.28 | -4.79% | 1,016,035 | +1.07% | +1.80% |